|
gptkbp:instance_of
|
gptkb:biotechnology
|
|
gptkbp:acquired
|
gptkb:Celularity_Inc.
|
|
gptkbp:acquisition
|
Virttu Biologics
Cure Pharmaceutical Holding Corp.
|
|
gptkbp:ceo
|
gptkb:Henry_Ji
|
|
gptkbp:clinical_trial
|
gptkb:vaccine
Phase 3 trials
pain management
cancer therapies
Phase 1 trials
Phase 2 trials
|
|
gptkbp:develops
|
cell therapies
COVID-19 therapies
antibody therapies
|
|
gptkbp:focus
|
gptkb:immunotherapy
|
|
gptkbp:focuses_on
|
gptkb:cancer_treatment
gptkb:immunotherapy
pain management
|
|
gptkbp:founded
|
gptkb:2006
|
|
gptkbp:founder
|
gptkb:Henry_Ji
|
|
gptkbp:funding
|
gptkb:venture_capital
public offerings
private placements
|
|
gptkbp:has_awards
|
Best Places to Work
Innovative Company Award
Top 100 Biotech Companies
|
|
gptkbp:has_collaborations_with
|
academic institutions
research organizations
biopharmaceutical companies
|
|
gptkbp:has_intellectual_property
|
patents
licenses
trademarks
|
|
gptkbp:has_product
|
COVI-TEST
COVI-TRACK
ZTlido
COVI-MSC
COVI-ANTIBODY
|
|
gptkbp:has_research_focus
|
gptkb:vaccine
gptkb:Cell
biologics
pain management
cancer immunotherapy
|
|
gptkbp:headquarters
|
gptkb:San_Diego,_California
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sorrento Therapeutics
|
|
gptkbp:partnership
|
gptkb:National_Institutes_of_Health
gptkb:University_of_California,_San_Diego
gptkb:Cleveland_Clinic
|
|
gptkbp:product
|
COVI-TEST
COVI-TRACK
ZTlido
COVI-MSC
|
|
gptkbp:stock_symbol
|
gptkb:SRNE
|
|
gptkbp:subsidiary
|
gptkb:Sorrento_Therapeutics_(Australia)_Pty_Ltd.
gptkb:Sorrento_Therapeutics_(Canada)_Inc.
gptkb:Sorrento_Therapeutics_(China)_Co.,_Ltd.
gptkb:Sorrento_Therapeutics_(Europe)_Gmb_H
gptkb:Sorrento_Therapeutics,_Inc.
|
|
gptkbp:traded_on
|
gptkb:NASDAQ
|
|
gptkbp:website
|
www.sorrentotherapeutics.com
|
|
gptkbp:bfsParent
|
gptkb:Ariad_Pharmaceuticals
gptkb:Agenus_Inc.
|
|
gptkbp:bfsLayer
|
5
|